Abstract:Background Neuroinflammation is an important host defense response to secondary brain injury after intracerebral hemorrhage (ICH). Triggering receptor expressed on myeloid cells 2 (TREM2) confers strong neuroprotective effects by attenuating neuroinflammation in experimental ischemic stroke. Recent studies suggest that apolipoprotein E (apoE) is a novel, high-affinity ligand of TREM2. This study aimed to investigate the effects of TREM2 activation on neuroinflammation and neuronal apoptosis in a mouse model of ICH. Methods Adult male CD1 mice (n = 216) were subjected to intrastriatal injection of bacterial collagenase. The TREM2 ligand, apoE-mimetic peptide COG1410 was administered intranasally at 1 h after ICH induction. To elucidate the underlying mechanism, TREM2 small interfering RNA (siRNA) and the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 were administered intracerebroventricularly prior to COG1410 treatment. Neurobehavioral tests, brain water content, immunofluorescence, western blotting, and Fluoro-Jade C- and terminal deoxynucleotidyl transferase dUTP nick end labeling staining were performed. Results Endogenous TREM2 expression was increased and peaked at 24 h after ICH. TREM2 was expressed on microglia, astrocytes, and neurons. COG1410 improved both short-term and long-term neurological functions, reduced brain edema, inhibited microglia/macrophage activation and neutrophil infiltration, and suppressed neuronal apoptotic cell death in perihematomal areas after ICH. Knockdown of endogenous TREM2 by TREM2 siRNA aggravated neurological deficits and decreased the expression of TREM2 in naive and ICH mice. COG1410 was associated with upregulation of TREM2, PI3K, phosphorylated-Akt, and Bcl-2 and downregulation of TNF-alpha, IL-1 beta, and Bax after ICH. The neuroprotective effects of COG1410 were abolished by both TREM2 siRNA and PI3K inhibitor LY294002. Conclusions Our finding demonstrated that TREM2 activation improved neurological functions and attenuated neuroinflammation and neuronal apoptosis after ICH, which was, at least in part, mediated by activation of PI3K/Akt signaling pathway. Therefore, activation of TREM2 may be a potential therapeutic strategy for the management of ICH patients.

Tat-Collapsin Response Mediator Protein 2 (CRMP2) Increases the Survival of Neurons After NMDA Excitotoxity by Reducing the Cleavage of CRMP2

Calcium-sensing Receptor Antagonist NPS2390 Attenuates Neuronal Apoptosis Though Intrinsic Pathway Following Traumatic Brain Injury in Rats.

Inhibition of Receptor-Interacting Protein 3 Upregulation and Nuclear Translocation Involved in Necrostatin-1 Protection Against Hippocampal Neuronal Programmed Necrosis Induced by Ischemia/reperfusion Injury.

Camkii Phosphorylates Collapsin Response Mediator Protein 2 and Modulates Axonal Damage During Glutamate Excitotoxicity

Calpain-Cleaved Collapsin Response Mediator Protein-3 Induces Neuronal Death after Glutamate Toxicity and Cerebral Ischemia

Collapsin Response Mediator Protein 3 Deacetylates Histone H4 to Mediate Nuclear Condensation and Neuronal Death

Calpain Cleavage of Collapsin Response Mediator Proteins in Ischemic Mouse Brain.

CRMP2 Participates in Regulating Mitochondrial Morphology and Motility in Alzheimer's Disease

Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications

CRMP2 improves memory deficits by enhancing the maturation of neuronal dendritic spines after traumatic brain injury.

Conventional protein kinase Cβ‐mediated phosphorylation inhibits collapsin response‐mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke‐induced mice

The Involvement of CRMP-2 on Axonal and Dendrictic Injury after Hypoxic-Ischemic Brain Injury in Neonatal Rat]

The Regulatory and Enzymatic Functions of CRMPs in Neuritogenesis, Synaptic Plasticity, and Gene Transcription.

cPKCβ-mediated phosphorylation inhibits CRMP2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke-induced mice.

Characterization of the Role of Full-Length CRMP3 and Its Calpain-Cleaved Product in Inhibiting Microtubule Polymerization and Neurite Outgrowth

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

Neuroprotection Against Neonatal Hypoxia/ischemia-Induced Cerebral Cell Death by Prevention of Calpain-Mediated Mglur1α Truncation

Collapsin response mediator protein(CRMP-2) promotes outgrowth of the hippocampal neurons

Cyclic AMP Response Element Modulator-1 (CREM-1) Involves in Neuronal Apoptosis after Traumatic Brain Injury

Calpain-truncated CRMP-3 and -4 Contribute to Potassium Deprivation-Induced Apoptosis of Cerebellar Granule Neurons.

PDZ Protein Interactions Underlying NMDA Receptor-Mediated Excitotoxicity and Neuroprotection by PSD-95 Inhibitors